SSRIs target prefrontal to raphe circuits during development modulating synaptic connectivity and emotional behavior.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
05 2019
Historique:
received: 14 03 2018
accepted: 06 09 2018
revised: 08 08 2018
pubmed: 4 10 2018
medline: 4 3 2020
entrez: 4 10 2018
Statut: ppublish

Résumé

Antidepressants that block the serotonin transporter, (Slc6a4/SERT), selective serotonin reuptake inhibitors (SSRIs) improve mood in adults but have paradoxical long-term effects when administered during perinatal periods, increasing the risk to develop anxiety and depression. The basis for this developmental effect is not known. Here, we show that during an early postnatal period in mice (P0-P10), Slc6a4/SERT is transiently expressed in a subset of layer 5-6 pyramidal neurons of the prefrontal cortex (PFC). PFC-SERT+ neurons establish glutamatergic synapses with subcortical targets, including the serotonin (5-HT) and GABA neurons of the dorsal raphe nucleus (DRN). PFC-to-DRN circuits develop postnatally, coinciding with the period of PFC Slc6a4/SERT expression. Complete or cortex-specific ablation of SERT increases the number of functional PFC glutamate synapses on both 5-HT and GABA neurons in the DRN. This PFC-to-DRN hyperinnervation is replicated by early-life exposure to the SSRI, fluoxetine (from P2 to P14), that also causes anxiety/depressive-like symptoms. We show that pharmacogenetic manipulation of PFC-SERT+ neuron activity bidirectionally modulates these symptoms, suggesting that PFC hypofunctionality has a causal role in these altered responses to stress. Overall, our data identify specific PFC descending circuits that are targets of antidepressant drugs during development. We demonstrate that developmental expression of SERT in this subset of PFC neurons controls synaptic maturation of PFC-to-DRN circuits, and that remodeling of these circuits in early life modulates behavioral responses to stress in adulthood.

Identifiants

pubmed: 30279456
doi: 10.1038/s41380-018-0260-9
pii: 10.1038/s41380-018-0260-9
pmc: PMC6445781
mid: NIHMS1506070
doi:

Substances chimiques

Antidepressive Agents 0
Serotonin Plasma Membrane Transport Proteins 0
Serotonin Uptake Inhibitors 0
Slc6a4 protein, mouse 0
Serotonin 333DO1RDJY

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

726-745

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH105839
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH098290
Pays : United States
Organisme : NIMH NIH HHS
ID : R56 MH105839
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Berardi N, Pizzorusso T, Maffei L. Critical periods during sensory development. Curr Opin Neurobiol. 2000;10:138–45.
doi: 10.1016/S0959-4388(99)00047-1
Hensch TK. Critical period regulation. Annu Rev Neurosci. 2004;27:549–79.
doi: 10.1146/annurev.neuro.27.070203.144327
Hensch TK. Critical period plasticity in local cortical circuits. Nat Rev Neurosci. 2005;6:877–88.
doi: 10.1038/nrn1787
Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science. 2004;306:879–81.
doi: 10.1126/science.1101678
Homberg JR, Schubert D, Gaspar P. New perspectives on the neurodevelopmental effects of SSRIs. Trends Pharmacol Sci. 2010;31:60–65.
doi: 10.1016/j.tips.2009.11.003
Rebello TJ, Yu Q, Goodfellow NM, Caffrey Cagliostro MK, Teissier A, Morelli E, et al. Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function. J Neurosci J Soc Neurosci. 2014;34:12379–93.
doi: 10.1523/JNEUROSCI.1020-13.2014
Suri D, Teixeira CM, Cagliostro MKC, Mahadevia D, Ansorge MS. Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors. Neuropsychopharmacol Publ Am Coll Neuropsychopharmacol. 2015;40:88–112.
doi: 10.1038/npp.2014.231
Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH, et al. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry. 2003;54:960–71.
doi: 10.1016/S0006-3223(03)00696-6
Alexandre C, Popa D, Fabre V, Bouali S, Venault P, Lesch K-P, et al. Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. J Neurosci J Soc Neurosci. 2006;26:5554–64.
doi: 10.1523/JNEUROSCI.5156-05.2006
Karg K, Burmeister M, Shedden K, Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry. 2011;68:444–54.
doi: 10.1001/archgenpsychiatry.2010.189
Wellman CL, Izquierdo A, Garrett JE, Martin KP, Carroll J, Millstein R, et al. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci J Soc Neurosci. 2007;27:684–91.
doi: 10.1523/JNEUROSCI.4595-06.2007
Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D, et al. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci. 2005;8:20–21.
doi: 10.1038/nn1366
Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci. 2005;8:828–34.
doi: 10.1038/nn1463
Drevets WC. Orbitofrontal cortex function and structure in depression. Ann N Y Acad Sci. 2007;1121:499–527.
doi: 10.1196/annals.1401.029
Mayberg HS. Targeted electrode-based modulation of neural circuits for depression. J Clin Invest. 2009;119:717–25.
doi: 10.1172/JCI38454
Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45:651–60.
doi: 10.1016/j.neuron.2005.02.014
Holtzheimer PE, Mayberg HS. Deep brain stimulation for psychiatric disorders. Annu Rev Neurosci. 2011;34:289–307.
doi: 10.1146/annurev-neuro-061010-113638
Amat J, Baratta MV, Paul E, Bland ST, Watkins LR, Maier SF. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat Neurosci. 2005;8:365–71.
doi: 10.1038/nn1399
Warden MR, Selimbeyoglu A, Mirzabekov JJ, Lo M, Thompson KR, Kim S-Y, et al. A prefrontal cortex-brainstem neuronal projection that controls response to behavioural challenge. Nature. 2012;492:428–32.
doi: 10.1038/nature11617
Challis C, Berton O. Top-down control of serotonin systems by the prefrontal cortex: a path toward restored socioemotional function in depression. ACS Chem Neurosci. 2015;6:1040–54.
doi: 10.1021/acschemneuro.5b00007
Lebrand C, Cases O, Wehrlé R, Blakely RD, Edwards RH, Gaspar P. Transient developmental expression of monoamine transporters in the rodent forebrain. J Comp Neurol. 1998;401:506–24.
doi: 10.1002/(SICI)1096-9861(19981130)401:4<506::AID-CNE5>3.0.CO;2-#
Cases O, Lebrand C, Giros B, Vitalis T, De Maeyer E, Caron MG, et al. Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs. J Neurosci J Soc Neurosci. 1998;18:6914–27.
doi: 10.1523/JNEUROSCI.18-17-06914.1998
Narboux-Nême N, Pavone LM, Avallone L, Zhuang X, Gaspar P. Serotonin transporter transgenic (SERTcre) mouse line reveals developmental targets of serotonin specific reuptake inhibitors (SSRIs). Neuropharmacology. 2008;55:994–1005.
doi: 10.1016/j.neuropharm.2008.08.020
Zhuang X, Masson J, Gingrich JA, Rayport S, Hen R. Targeted gene expression in dopamine and serotonin neurons of the mouse brain. J Neurosci Methods. 2005;143:27–32.
doi: 10.1016/j.jneumeth.2004.09.020
Sousa VH, Miyoshi G, Hjerling-Leffler J, Karayannis T, Fishell G. Characterization of Nkx6-2-derived neocortical interneuron lineages. Cereb Cortex N Y N 1991. 2009;19 Suppl 1:i1–10.
Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010;13:133–40.
doi: 10.1038/nn.2467
Gorski JA, Talley T, Qiu M, Puelles L, Rubenstein JLR, Jones KR. Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage. J Neurosci J Soc Neurosci. 2002;22:6309–14.
doi: 10.1523/JNEUROSCI.22-15-06309.2002
Chen X, Ye R, Gargus JJ, Blakely RD, Dobrenis K, Sze JY. Disruption of transient serotonin accumulation by non-serotonin-producing neurons impairs cortical map development. Cell Rep. 2015. https://doi.org/10.1016/j.celrep.2014.12.033
doi: 10.1016/j.celrep.2014.12.033 pubmed: 26725113 pmcid: 4706775
Chen X, Petit EI, Dobrenis K, Sze JY. Spatiotemporal SERT expression in cortical map development. Neurochem Int. 2016;98:129–37.
doi: 10.1016/j.neuint.2016.05.010
Armbruster BN, Li X, Pausch MH, Herlitze S, Roth BL. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc Natl Acad Sci USA. 2007;104:5163–8.
doi: 10.1073/pnas.0700293104
Micheva KD, Smith SJ. Array tomography: a new tool for imaging the molecular architecture and ultrastructure of neural circuits. Neuron. 2007;55:25–36.
doi: 10.1016/j.neuron.2007.06.014
Soiza-Reilly M, Commons KG. Quantitative analysis of glutamatergic innervation of the mouse dorsal raphe nucleus using array tomography. J Comp Neurol. 2011;519:3802–14.
doi: 10.1002/cne.22734
Meye FJ, Soiza-Reilly M, Smit T, Diana MA, Schwarz MK, Mameli M. Shifted pallidal co-release of GABA and glutamate in habenula drives cocaine withdrawal and relapse. Nat Neurosci. 2016;19:1019–24.
doi: 10.1038/nn.4334
Soiza-Reilly M, Anderson WB, Vaughan CW, Commons KG. Presynaptic gating of excitation in the dorsal raphe nucleus by GABA. Proc Natl Acad Sci USA. 2013;110:15800–5.
doi: 10.1073/pnas.1304505110
Marinelli S, Schnell SA, Hack SP, Christie MJ, Wessendorf MW, Vaughan CW. Serotonergic and nonserotonergic dorsal raphe neurons are pharmacologically and electrophysiologically heterogeneous. J Neurophysiol. 2004;92:3532–7.
doi: 10.1152/jn.00437.2004
Brown RE, McKenna JT, Winston S, Basheer R, Yanagawa Y, Thakkar MM, et al. Characterization of GABAergic neurons in rapid-eye-movement sleep controlling regions of the brainstem reticular formation in GAD67-green fluorescent protein knock-in mice. Eur J Neurosci. 2008;27:352–63.
doi: 10.1111/j.1460-9568.2008.06024.x
Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinforma Oxf Engl. 2009;25:1105–11.
doi: 10.1093/bioinformatics/btp120
Anders S, Pyl PT, Huber W. HTSeq--a python framework to work with high-throughput sequencing data. Bioinforma Oxf Engl. 2015;31:166–9.
doi: 10.1093/bioinformatics/btu638
Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11:R106.
doi: 10.1186/gb-2010-11-10-r106
Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.
doi: 10.1038/nprot.2008.211
Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 1977;229:327–36.
pubmed: 596982
Blakely RD, Berson HE, Fremeau RT Jr, Caron MG, Peek MM, Prince HK, et al. Cloning and expression of a functional serotonin transporter from rat brain. Nature. 1991;354:66–70.
doi: 10.1038/354066a0
Lebrand C, Cases O, Adelbrecht C, Doye A, Alvarez C, El Mestikawy S, et al. Transient uptake and storage of serotonin in developing thalamic neurons. Neuron. 1996;17:823–35.
doi: 10.1016/S0896-6273(00)80215-9
Verney C, Lebrand C, Gaspar P. Changing distribution of monoaminergic markers in the developing human cerebral cortex with special emphasis on the serotonin transporter. Anat Rec. 2002;267:87–93.
doi: 10.1002/ar.10089
Wyler SC, Donovan LJ, Yeager M, Deneris E. Pet-1 controls tetrahydrobiopterin pathway and Slc22a3 transporter genes in serotonin neurons. ACS Chem Neurosci. 2015;6:1198–205.
doi: 10.1021/cn500331z
Molyneaux BJ, Arlotta P, Menezes JRL, Macklis JD. Neuronal subtype specification in the cerebral cortex. Nat Rev Neurosci. 2007;8:427–37.
doi: 10.1038/nrn2151
Chevée M, Robertson JDJ, Cannon GH, Brown SP, Goff LA. Variation in activity state, axonal projection, and position define the transcriptional identity of individual neocortical projection neurons. Cell Rep. 2018;22:441–55.
doi: 10.1016/j.celrep.2017.12.046
Sesack SR, Deutch AY, Roth RH, Bunney BS. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol. 1989;290:213–42.
doi: 10.1002/cne.902900205
Vertes RP. Differential projections of the infralimbic and prelimbic cortex in the rat. Synap N Y N. 2004;51:32–58.
doi: 10.1002/syn.10279
Gabbott PLA, Warner TA, Jays PRL, Salway P, Busby SJ. Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers. J Comp Neurol. 2005;492:145–77.
doi: 10.1002/cne.20738
Arlotta P, Molyneaux BJ, Chen J, Inoue J, Kominami R, Macklis JD. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron. 2005;45:207–21.
doi: 10.1016/j.neuron.2004.12.036
Leyva-Díaz E, López-Bendito G. In and out from the cortex: development of major forebrain connections. Neuroscience. 2013;254:26–44.
doi: 10.1016/j.neuroscience.2013.08.070
Weissbourd B, Ren J, DeLoach KE, Guenthner CJ, Miyamichi K, Luo L. Presynaptic partners of dorsal raphe serotonergic and GABAergic neurons. Neuron. 2014;83:645–62.
doi: 10.1016/j.neuron.2014.06.024
Peyron C, Petit JM, Rampon C, Jouvet M, Luppi PH. Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience. 1998;82:443–68.
doi: 10.1016/S0306-4522(97)00268-6
Soiza-Reilly M, Commons KG. Glutamatergic drive of the dorsal raphe nucleus. J Chem Neuroanat. 2011;41:247–55.
doi: 10.1016/j.jchemneu.2011.04.004
Fremeau RT Jr, Troyer MD, Pahner I, Nygaard GO, Tran CH, Reimer RJ, et al. The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron. 2001;31:247–60.
doi: 10.1016/S0896-6273(01)00344-0
Challis C, Beck SG, Berton O. Optogenetic modulation of descending prefrontocortical inputs to the dorsal raphe bidirectionally bias socioaffective choices after social defeat. Front Behav Neurosci. 2014;8:43.
doi: 10.3389/fnbeh.2014.00043
Arnsten AFT. Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci. 2009;10:410–22.
doi: 10.1038/nrn2648
Altamura C, Dell’Acqua ML, Moessner R, Murphy DL, Lesch KP, Persico AM. Altered neocortical cell density and layer thickness in serotonin transporter knockout mice: a quantitation study. Cereb Cortex N Y N 1991. 2007;17:1394–401.
Schubert D, Martens GJM, Kolk SM. Molecular underpinnings of prefrontal cortex development in rodents provide insights into the etiology of neurodevelopmental disorders. Mol Psychiatry. 2015;20:795–809.
doi: 10.1038/mp.2014.147
Benekareddy M, Goodfellow NM, Lambe EK, Vaidya VA. Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability. J Neurosci J Soc Neurosci. 2010;30:12138–50.
doi: 10.1523/JNEUROSCI.3245-10.2010
Beier KT, Steinberg EE, DeLoach KE, Xie S, Miyamichi K, Schwarz L, et al. Circuit Architecture of VTA Dopamine Neurons Revealed by Systematic Input-Output Mapping. Cell. 2015;162:622–34.
doi: 10.1016/j.cell.2015.07.015
Sharp T, Boothman L, Raley J, Quérée P. Important messages in the ‘post’: recent discoveries in 5-HT neurone feedback control. Trends Pharmacol Sci. 2007;28:629–36.
doi: 10.1016/j.tips.2007.10.009
Veerakumar A, Challis C, Gupta P, Da J, Upadhyay A, Beck SG, et al. Antidepressant-like effects of cortical deep brain stimulation coincide with pro-neuroplastic adaptations of serotonin systems. Biol Psychiatry. 2014;76:203–12.
doi: 10.1016/j.biopsych.2013.12.009
Geddes SD, Assadzada S, Lemelin D, Sokolovski A, Bergeron R, Haj-Dahmane S, et al. Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids. Proc Natl Acad Sci USA. 2016. https://doi.org/10.1073/pnas.1522754113
doi: 10.1073/pnas.1522754113 pubmed: 27114535
Soiza-Reilly M, Commons KG. Unraveling the architecture of the dorsal raphe synaptic neuropil using high-resolution neuroanatomy. Front Neural Circuits. 2014;8:105.
doi: 10.3389/fncir.2014.00105
Hajós M, Hajós-Korcsok E, Sharp T. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat. Br J Pharmacol. 1999;126:1741–50.
doi: 10.1038/sj.bjp.0702510
Teissier A, Chemiakine A, Inbar B, Bagchi S, Ray RS, Palmiter RD, et al. Activity of Raphé Serotonergic Neurons Controls Emotional Behaviors. Cell Rep. 2015;13:1965–76.
doi: 10.1016/j.celrep.2015.10.061
Darling RD, Alzghoul L, Zhang J, Khatri N, Paul IA, Simpson KL, et al. Perinatal citalopram exposure selectively increases locus ceruleus circuit function in male rats. J Neurosci J Soc Neurosci. 2011;31:16709–15.
doi: 10.1523/JNEUROSCI.3736-11.2011
Simpson KL, Weaver KJ, de Villers-Sidani E, Lu JY-F, Cai Z, Pang Y, et al. Perinatal antidepressant exposure alters cortical network function in rodents. Proc Natl Acad Sci USA. 2011;108:18465–70.
doi: 10.1073/pnas.1109353108
Salichon N, Gaspar P, Upton AL, Picaud S, Hanoun N, Hamon M, et al. Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. J Neurosci J Soc Neurosci. 2001;21:884–96.
doi: 10.1523/JNEUROSCI.21-03-00884.2001
Laurent A, Goaillard J-M, Cases O, Lebrand C, Gaspar P, Ropert N. Activity-dependent presynaptic effect of serotonin 1B receptors on the somatosensory thalamocortical transmission in neonatal mice. J Neurosci J Soc Neurosci. 2002;22:886–900.
doi: 10.1523/JNEUROSCI.22-03-00886.2002
Rebsam A, Seif I, Gaspar P. Refinement of thalamocortical arbors and emergence of barrel domains in the primary somatosensory cortex: a study of normal and monoamine oxidase a knock-out mice. J Neurosci J Soc Neurosci. 2002;22:8541–52.
doi: 10.1523/JNEUROSCI.22-19-08541.2002
Wirth A, Holst K, Ponimaskin E. How serotonin receptors regulate morphogenic signalling in neurons. Prog Neurobiol. 2016. https://doi.org/10.1016/j.pneurobio.2016.03.007
doi: 10.1016/j.pneurobio.2016.03.007 pubmed: 27013076
Oberlander TF, Papsdorf M, Brain UM, Misri S, Ross C, Grunau RE. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Arch Pediatr Adolesc Med. 2010;164:444–51.
doi: 10.1001/archpediatrics.2010.51
Hanley GE, Brain U, Oberlander TF. Prenatal exposure to serotonin reuptake inhibitor antidepressants and childhood behavior. Pediatr Res. 2015;78:174–80.
doi: 10.1038/pr.2015.77
Malm H, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague IW, et al. Gestational exposure to selective serotonin reuptake inhibitors and offspring psychiatric disorders: a national register-based study. J Am Acad Child Adolesc Psychiatry. 2016;55:359–66.
doi: 10.1016/j.jaac.2016.02.013
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527–31.
doi: 10.1126/science.274.5292.1527
Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, et al. Serotonin transporter genetic variation and the response of the human amygdala. Science. 2002;297:400–3.
doi: 10.1126/science.1071829
Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–9.
doi: 10.1126/science.1083968

Auteurs

M Soiza-Reilly (M)

Institut du Fer à Moulin, Paris, France.
Inserm, UMR-S 839, Paris, France.
Sorbonne Universités, Paris, France.

F J Meye (FJ)

Institut du Fer à Moulin, Paris, France.
Inserm, UMR-S 839, Paris, France.
Sorbonne Universités, Paris, France.

J Olusakin (J)

Institut du Fer à Moulin, Paris, France.
Inserm, UMR-S 839, Paris, France.
Sorbonne Universités, Paris, France.

L Telley (L)

Department of Basic Neurosciences, University of Geneva, Geneva, Switzerland.

E Petit (E)

Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA.

X Chen (X)

Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA.

M Mameli (M)

Institut du Fer à Moulin, Paris, France.
Inserm, UMR-S 839, Paris, France.
Sorbonne Universités, Paris, France.

D Jabaudon (D)

Department of Basic Neurosciences, University of Geneva, Geneva, Switzerland.

J-Y Sze (JY)

Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA.

P Gaspar (P)

Institut du Fer à Moulin, Paris, France. patricia.gaspar@inserm.fr.
Inserm, UMR-S 839, Paris, France. patricia.gaspar@inserm.fr.
Sorbonne Universités, Paris, France. patricia.gaspar@inserm.fr.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH